FDA Asks E&C For New Authority On Opioid Evaluation, Seizure

February 08, 2018
FDA officials met Tuesday (Feb. 6) with House Energy & Commerce Committee members, including Rep. David McKinley (R-WV), to discuss policies to strengthen FDA's power to curb opioid abuse, including enshrining in law FDA's ability to consider drug-abuse risk in product reviews. The document, provided by McKinley to Inside Health Policy , also suggests that Congress give FDA more power to enforce post-market testing, impose new packaging and disposal restrictions on drug makers and increase FDA's authority to seize drugs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.